Toshinori Agatsuma
7PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 10, 2025
DS-3939a: A TA-MUC1-Directed Antibody-Drug Conjugate with Broad Antitumor Activity.Kohei Takano, Mayuko Yukiura, Kazuki Takahashi
|Jan 11, 2024
Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models.Hirokazu Suzuki, Shotaro Nagase, Chiemi Saito
|Feb 12, 2022
DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models.Michiko Yamato, Jun Hasegawa, Takanori Maejima
|Aug 20, 2021
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.Daisuke Okajima, Satoru Yasuda, Takanori Maejima
|Feb 13, 2021
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate.Kenji Iida, Amr H Abdelhamid Ahmed, Akiko Kawano Nagatsuma
|Sep 01, 2019
A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization.Yuuri Hashimoto, Kumiko Koyama, Yasuki Kamai
Pageof 2
Frequent Collaborators
2 joint publications
Taisei Nomura
2 joint publications
Yuki Abe
2 joint publications
Kokichi Honda
2 joint publications
Takanori Maejima
2 joint publications
Kazuyoshi Kumagai
1 joint publications
Takashi Kagari
1 joint publications
Masaharu Hanai
1 joint publications
Kenji Iida
1 joint publications
Amr H Abdelhamid Ahmed
1 joint publications
Sandro Santagata
